Form 4 for DFTX Definium Therapeutics, Inc.
Accepted 2024-03-26 00:00:00 ET · period of report 2024-03-25 · accession 0000950170-24-036578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-26 | 2024-03-25 | DFTX | Greenway Schond L. | CFO | F - Tax | $9.78 | -5,560 | 211.1K | -3% | -$54.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-03-25 | F | D | 5,560 | $9.78 | 211,057 | D | — | — | (F1) Represents the number of Common Shares withheld to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, as permitted by the Issuer's Performance and Restricted Share Unit Plan. |